| First Author | Mishra A | Year | 2024 |
| Journal | iScience | Volume | 27 |
| Issue | 1 | Pages | 108748 |
| PubMed ID | 38235330 | Mgi Jnum | J:344337 |
| Mgi Id | MGI:7575328 | Doi | 10.1016/j.isci.2023.108748 |
| Citation | Mishra A, et al. (2024) Atrial natriuretic peptide signaling co-regulates lipid metabolism and ventricular conduction system gene expression in the embryonic heart. iScience 27(1):108748 |
| abstractText | It has been shown that atrial natriuretic peptide (ANP) and its high affinity receptor (NPRA) are involved in the formation of ventricular conduction system (VCS). Inherited genetic variants in fatty acid oxidation (FAO) genes are known to cause conduction abnormalities in newborn children. Although the effect of ANP on energy metabolism in noncardiac cell types is well documented, the role of lipid metabolism in VCS cell differentiation via ANP/NPRA signaling is not known. In this study, histological sections and primary cultures obtained from E11.5 mouse ventricles were analyzed to determine the role of metabolic adaptations in VCS cell fate determination and maturation. Exogenous treatment of E11.5 ventricular cells with ANP revealed a significant increase in lipid droplet accumulation, FAO and higher expression of VCS marker Cx40. Using specific inhibitors, we further identified PPARgamma and FAO as critical downstream regulators of ANP-mediated regulation of metabolism and VCS formation. |
